High Grade Serous Ovarian Cancer Clinical Trial
Official title:
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian cance
After being informed about the study and potential risks, all patient giving wirtting informed consent. During surgery, tissue and blood samples will be conserved for the study. In this study will be compared images obtained in vivo before surgical management, ex vivo images obtained on excised tissues during surgery, histological data obtained during surgery. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05146505 -
miRNAs in High Grade Serous Ovarian Cancer
|
||
| Recruiting |
NCT06136884 -
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT01853306 -
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
|
Phase 1 | |
| Terminated |
NCT05329545 -
Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)
|
Phase 3 | |
| Active, not recruiting |
NCT01883297 -
"Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
|
Phase 1 | |
| Recruiting |
NCT05512208 -
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
|
Phase 2 | |
| Recruiting |
NCT04261465 -
NUVOLA TRIAL Open-label Multicentre Study
|
Phase 2 | |
| No longer available |
NCT03123211 -
Expanded Access to Veliparib
|